Business Context and Reporting Period
This Form 8-K Current Report is filed by NanoViricides, Inc. (NNVC), a Nevada corporation listed on the NYSE-American. The report covers events occurring on July 31, 2019, with the filing date of August 1, 2019.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the departure of a director:
- Resignation: Dr. Mukund Kulkarni resigned as a Member of the Board of Directors, as well as from the Audit, Nominating, and Compensation Committees, effective July 31, 2019.
- Reason: The resignation was for personal reasons.
- Disagreement: Dr. Kulkarni did not indicate that his resignation resulted from any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The report is limited to the disclosure of the director's resignation.
Investor Verification Checklist
- Verify the impact of Dr. Kulkarni's departure on the composition of the Audit, Nominating, and Compensation Committees.
- Confirm whether the Board has initiated a search for a replacement director to fill the vacancy.
- Review the attached resignation letter (Exhibit 17.1) for any additional context not summarized in the main text.